Fulcrum Therapeutics, Inc. (FULC) vs Standard BioTools Inc. (LAB)
A side-by-side comparison of Fulcrum Therapeutics, Inc. and Standard BioTools Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
FULC
Fulcrum Therapeutics, Inc.
$3.70HealthcareDelayed quote: Oct 6, 2026, 12:54 PM EDT
LAB
Standard BioTools Inc.
$0.74HealthcareDelayed quote: Oct 6, 2026, 12:50 PM EDT
Total return — FULC vs LAB
growth of $100 · dividends reinvested · last 7yFULC -72.5% (-16.8%/yr)LAB -93.2% (-32.0%/yr)FULC compounded faster over this window
FULC LAB
FULC vs LAB: by the numbers
- •LAB is the larger company ($288M vs $282M market cap).
- •Both run net losses; FULC's is the smaller (0.00% vs -103.29% net margin).
Metrics side by side
Valuation
| Metric | FULC | LAB |
|---|---|---|
| P/S ratio | N/A | 3.41 |
| P/B ratio | 0.91 | 0.53 |
Profitability
| Metric | FULC | LAB |
|---|---|---|
| Gross margin | 0.00% | 49.14% |
| Operating margin | 0.00% | -109.34% |
| Net margin | 0.00% | -103.29% |
| ROE | -27.36% | -16.18% |
| ROIC | -27.62% | -14.06% |
Growth (annualized)
| Metric | FULC | LAB |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -10.62% |
| Total return CAGR (5Y) | -31.70% | -32.98% |
Frequently asked
- How have FULC and LAB total returns compared?
- Over the past 5 years, FULC delivered -31.70% and LAB delivered -32.98% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.